Nearsightedness Clinical Trials

Find Nearsightedness Clinical Trials Near You

Advancing Myopia Control in Children: A Randomized Controlled Trial of Two Novel Daily Disposable Contact Lenses

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this study is to investigate the myopic control efficacy of two study soft contact lenses in children. Participants will be prescribed Lens A, Lens B or single vision contact lenses for the first year. Participants in single vision contact lenses group will switch to Lens A at 12 months. All participants will then continue lens wear for an additional 12 months. Their cycloplegic refraction and axial length will be monitored every 6 months for 2 years.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 7
Maximum Age: 12
Healthy Volunteers: f
View:

• • Age at enrolment: 7 - 12 (both inclusive) years old Hong Kong Chinese schoolchildren

‣ Refractive errors in terms of spherical equivalent refraction (SER) determined by cycloplegic autorefraction: -0.75 diopters (D) to -5.00D in both eyes

⁃ Astigmatism: equal or less than -1.00D

⁃ Anisometropia: equal or less than -1.75D

⁃ Previous myopia progression:

• -0.50D (in SER) per year or more in 1 eye or both eyes OR Axial length elongation: 0.27mm/year in 1 eye or both eyes

∙ If myopia is initially detected during screening, eligibility requires an SER below the 3rd percentile curve of refraction in either or both eyes (4)

⁃ Best corrected visual acuity: better than 0.04 LogMAR in both eyes

⁃ Ocular health: no abnormalities in both internal and external ocular health

⁃ Systemic health: no systemic interference with ocular vision functioning

⁃ Binocular vision: no strabismus and other binocular abnormalities

⁃ No medication or supplements that affect eye growth

⁃ Normal colour vision

⁃ No previous use of myopic control interventions such as red-light therapy, atropine, orthokeratology, specialized spectacle lenses and contact lenses and oral supplements for myopic control

⁃ Agree to maintain the visit schedule and be able to keep all appointments as specified in the informed assent and consent forms throughout study duration.

⁃ Agree to accept either the control or study lens as assigned by the randomization scheme

⁃ Agree to wear the assigned contact lenses for a minimum of 10 hours per day, at least 6 days per week, for the duration of the 2-year study and to inform the study investigator if this schedule is interrupted. Wearing time may be modified by the study staff for health reasons

⁃ Agree to adhere to contact lens use requirements throughout study duration

⁃ Acceptance of the masked study design

Locations
Other Locations
Hong Kong Special Administrative Region
Optometry Research Clinic, School of Optometry, The Hong Kong Polytechnic University
RECRUITING
Kowloon
Contact Information
Primary
Rachel Ka Man Chun, PhD
rachel.chun@polyu.edu.hk
852-27664224
Backup
Dennis Yan Yin Tse, PhD
dennis.tse@polyu.edu.hk
852-27666096
Time Frame
Start Date: 2026-08-26
Estimated Completion Date: 2029-07-14
Participants
Target number of participants: 126
Treatments
No_intervention: Single vision lens group
Participants in single vision contact lens group will receive single vision contact lenses for initial 12 months. They will switch to Lens A at 12-month mark for an additional 12 months.
Experimental: Lens A group
Participants in Lens A group will receive Lens A contact lenses for 24 months.
Experimental: Lens B group
Participants in Lens B group will receive Lens B contact lenses for 24 months.
Related Therapeutic Areas
Sponsors
Leads: The Hong Kong Polytechnic University
Collaborators: Eyebright Medical Technology (Beijing) Co., Ltd.

This content was sourced from clinicaltrials.gov